Russian lung cancer patients under the microscope: durvalumab in daily practice

NCT ID NCT05456867

First seen Mar 22, 2026 · Last updated May 15, 2026 · Updated 8 times

Summary

This study looks at how the drug durvalumab works in everyday medical practice for people with a certain type of advanced lung cancer (NSCLC) that cannot be removed by surgery. Researchers will track about 250 patients in Russia to see how safe the drug is and how long people stay on treatment. The goal is to learn more about real-world outcomes, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC, NON-SMALL-CELL LUNG CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Arkhangelsk, Russia

  • Research Site

    Chelyabinsk, Russia

  • Research Site

    Grozny, Russia

  • Research Site

    Irkutsk, Russia

  • Research Site

    Khanty-Mansiysk, Russia

  • Research Site

    Kostroma, Russia

  • Research Site

    Krasnodar, Russia

  • Research Site

    Krasnoyarsk, Russia

  • Research Site

    Moscow, Russia

  • Research Site

    Murmansk, Russia

  • Research Site

    Nizhny Novgorod, Russia

  • Research Site

    Novosibirsk, Russia

  • Research Site

    Perm, Russia

  • Research Site

    Saint Petersburg, Russia

  • Research Site

    Sochi, Russia

  • Research Site

    Surgut, Russia

  • Research Site

    Tomsk, Russia

  • Research Site

    Ufa, Russia

  • Research Site

    Vologda, Russia

  • Research Site

    Yaroslavl, Russia

  • Research Site

    Yekaterinburg, Russia

  • Research Site

    Yuzhno-Sakhalinsk, Russia

Conditions

Explore the condition pages connected to this study.